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Summary gion of this county to be 1%. The frequency of heterozy-
gous carriers was estimated to be 10%–26%. All of
Niemann-Pick type II disease is a severe disorder charac- these individuals were shown to have descended from a
terized by accumulation of tissue cholesterol and sphin- small set of common ancestors, who emigrated from
gomyelin and by progressive degeneration of the nervous France to Nova Scotia during the 1600s. These demo-
system. This disease has two clinically similar subtypes,
graphics provide an opportunity to localize the defective
type C (NPC) and type D (NPD). NPC is clinically vari-
gene in these patients, through a strategy of linkage anal-
able and has been identiﬁed in many ethnic groups.
ysis.NPD, on the other hand, has been reported only in de-
Niemann-Pick type II disease has been classiﬁed intoscendants of an Acadian couple who lived in Nova Sco-
two subtypes, C and D (Crocker and Farber 1958;tia in the early 18th century and has a more homoge-
Crocker 1961). The type C form (NPC) has been docu-neous expression resembling that of less severely
mented in many ethnic groups and is biochemically andaffected NPC patients. Despite biochemical differences,
clinically heterogeneous in nature (Vanier et. al. 1991;it has not been established whether NPC and NPD are
Higgins et. al. 1992), whereas the type D form (NPD)allelic variants of the same disease. We report here that
is conﬁned to descendants of the Acadian populationNPD is tightly linked (recombination fraction .00; maxi-
of southwest Nova Scotia and is more homogeneous.mum LOD score 4.50) to a microsatellite marker,
Liscum and Faust (1987) have shown that NPC cellsD18S480, from the centromeric region of chromosome
possess the ability to bind, internalize, and degrade LDL18q. Carstea et al. have reported that the NPC gene
normally. However, some cellular responses to LDL—maps to this same site; therefore we suggest that NPC
for example, stimulation of cholesterol esteriﬁcation byand NPD likely result from mutations in the same gene.
acyl-CoA:cholesterol acyltransferase (ACAT) and
down-regulation of cholesterol synthesis and LDL-
Introduction receptor expression—are reduced (Pentchev et. al.
1985, 1986). These observations are consistent with an
Niemann-Pick type II disease is an autosomal recessive
LDL-speciﬁc regulatory defect.
disorder usually occurring in childhood. It is character-
Complementation studies, which assess the possibilityized clinically by severe, progressive degeneration of the
of genetic heterogeneity, indicate that NPC comprises atnervous system, coincident with accumulation of tissue
least two complementation groups. Steinberg et al. (1994)cholesterol and sphingomyelin (Spence and Callahan
have provided evidence of a second complementation1989; Pentchev et. al. 1995). The causative gene defect
group, consisting of 1 of their 12 NPC patients. Vanierassociated with this disorder has not yet been identiﬁed.
et. al. (1996) similarly have described both a major com-Yarmouth County of Nova Scotia is reported to have
plementation group comprising 27 of 32 unrelated pa-the world’s highest incidence of Niemann-Pick type II
tients and a second group comprising the remaining 5disease (Vethamany et. al. 1972; Winsor and Welch
patients. These ﬁve patients include the latter individual1978). An extensive study by Winsor and Welch in 1978
described by Steinberg. The full range of clinical and bio-estimated the frequency of affected children in one re-
chemical phenotypes were observed within the major
NPC group, and no distinguishing characteristic was as-
sociated with the minor group. Carstea et al. (1994)
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Table 1 origin (Winsor and Welch 1978); these 130 individuals
include 7 patients and 20 obligate carriers.
Maximum-Likelihood Estimates of uˆ between Niemann-Pick
Disease Type D and Chromosome 18 Markers, and
Genotyping by Microsatellite AnalysisAssociated Two-Point LOD Score (Z)
The polymorphic microsatellite markers used in this
Polymorphic Position study include D18S40, D18S869, D18S44, D18S1101,
Marker (cM from D18S40) uˆ Z D18S1108, D18S480, D18S975, D18S66, D18S478,
and D18S1151 from the centromeric region of chromo-D18S40 0 .05 1.99
some 18. Total genomic DNA was extracted from allD18S869 5 .00 3.10
D18S44 6 .00 1.93 samples by use of standard high-salt extraction proce-
D18S1101 7 .00 3.33 dures, and the alleles at each locus were ampliﬁed by
D18S1108 7 .04 3.38 PCR using conditions and primers described in the Ge-
D18S480 9 .00 4.50
nome Data Base (GDB) (http://gdbwww.gdb.org/) and/D18S975 11 .00 2.66
or the Whitehead Institute Data base (http:/www-D18S66 13 .10 1.90
D18S478 15 .07 1.33 genome.wi.MIT.edu).
D18S1151 15 .08 1.88 In brief, Ç250 ng of genomic DNA was PCR ampli-
ﬁed in a 25-ml reaction mix containing 1.25 U Taq poly-
merase (Gibco BRL), 1.5–2.0 mM MgCl2, 50 mM KCl,
10 mM Tris-HCl, pH 8.3 (with the exception of 25 mMbiochemical properties of the Nova Scotia form (NPD)
Tris-HCl pH 9.3, for amplication of D18S66, D18S40,of Niemann-Pick type II disease. Byers et al. (1989) ini-
and D18S1108 allelles), 400 mM each dNTP, 1 mCi 32P-tially showed that NPD ﬁbroblasts exhibit a delayed and
dCTP, and 0.1–1 mM each primer. The reactions werepartial increase in cholesterol esteriﬁcation in response
denatured at 95C for 5 min and then were subjectedto LDL. This is contrasted by the rapid or absent stimu-
to 30 cycles of 95C, 55C (for D18S869, D18S44,lations noted in normal or more severely affected NPC
D18S1101, D18S1108, D18S480, D18S478, andcells, respectively. The distinct mutations in NPC and
D18S1151) or 57C (for D18S66, D18S975, andNPD also result in differences in other regulatory steps
in cholesterol metabolism (Sidhu et al. 1993). Down-
regulation of LDL receptor, measured by northern blots
of LDL receptor mRNA, was substantially delayed only
in severely affected NPC cells. Filipin ﬂuorescence stain-
ing of stored cholesterol was found to be much less
pronounced in NPD than in many NPC ﬁbroblasts.
These studies established that NPD, like NPC, is defec-
tive in regulation of intracellular cholesterol esteriﬁca-
tion and storage, althoughNPD is a homogeneous group
with some speciﬁcities.
Despite these differences, present evidence suggests
that NPD and NPC may be allelic variants. Complemen-
tation of cholesterol esteriﬁcation was not observed ei-
ther when NPC and NPD ﬁbroblasts were fused with
polyethylene glycol (Sidhu et al. 1993) or when activity
was measured directly in mixed-cell homogenates (Byers
et al. 1989). The linkage analysis presented here exam-
ines the hypothesis that the genetic defect segregating in
the Nova Scotian NPD population is an allelic variant
of NPC, by testing for linkage to the chromosome 18
Figure 1 Location scores from multipoint linkage analysis for
region that contains NPC. placement of the NPD gene relative to marker loci. The horizontal
axis of this plot represents the genetic-linkage map of marker loci from
the centromeric region of chromosome 18, with D18S40 arbitrarilySubjects and Methods
positioned at 0.0 cM. This map was constructed by two-point linkage
Subjects analysis of the NPD pedigrees. Shown are eight overlapping curves
representing the likelihood support for the map position of NPD rela-Peripheral blood and/or parafﬁn-embedded tissue was
tive to marker loci, each curve representing a different set of threecollected, with ethical approval from the IWK Grace
adjacent marker loci. These data indicate that NPD most likely maps
Maternity Health Centre for Children (Halifax), from either in the interval between D18S1108 and D18S66 or in the interval
130 members of four extended families all of whom can between D18S40 and D18S1101. NPC is located between D18S44
and D18S1101.be traced to at least one common ancestor of French
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Figure 2 Meiotic recombination, which positions D18S478 distal to D18S66. Directly below each individual in the pedigree, the allele
sizes (in bp) at each locus are indicated in the order in which they occur on the chromosome. The phase of these alleles is clearly established
by comparison with that in other family members. Haplotypes are further depicted as shaded bars.
D18S40), and 72C, with a ﬁnal 7–10-min extension at two recombinant chromosomes that place D18S478 dis-
tal to D18S66 (ﬁg. 2).72C. Amplicons were size fractionated by electrophore-
sis on standard sequencing gels and were sized by com- To position the NPD locus relative to the linked
marker loci, multipoint analyses comparing the relativeparison with a comigratory M13 sequence ladder gener-
ated by use of the Sequenase version 2 kit (Amersham). likelihoods of various NPD locations were performed;
the results are represented in ﬁgure 1. These data are
Linkage Analysis most consistent with placement of NPD either in the
Two-point and four-point linkage analyses of NPD interval between D18S1108 and D18S66 (peak location
and the 10 microsatellite marker loci were performed score 28.0 at locus D18S480) or in the interval between
by use of the FASTLINK versions of the MLINK and D18S40 and D18S1101 (peak location score 23.8 at
LINKMAP programs (Lathrop et al. 1984; Cottingham D18S44).
et al. 1993). In the ﬁgure illustrating the results of the
multipoint analysis, the location scores for both internal Discussion
intervals for all four-point analyses were plotted.
The results reported here show tight linkage between
NPD and polymorphic microsatellite marker loci from
Results
the centromeric region of chromosome 18, previously
shown by Carstea et al. (1993) to be linked to the NPCThe maximum-likelihood estimates for recombina-
tion fractions (uO ) between NPD and each of the 10 locus. Although one cannot exclude the possibility that
these disorders result from defects in separate genes lo-marker loci are shown in table 1. These data reveal close
linkage (uO Å .00) of the disease locus to ﬁve loci in this cated close together, it is reasonable to assume that they
are allelic variants. This conclusion is consistent with theregion—D18S869, D18S44, D18S1101, D18S480, and
D18S975. The highest maximum LOD score (Zmax) was apparent lack of complementation observed in previous
studies (Byers et al. 1989; Sidhu et al. 1993). The clinical4.50 for NPD–D18S480.
Pairwise linkage analysis between marker loci has and biochemical phenotypes of NPC patients are vari-
able. NPD likely represents one of the milder variants.generated a genetic linkage map, which is depicted in
ﬁgure 1. The gene order indicated by these results is A genetic map of the 10 microsatellite markers studied
in this report has been generated from pairwise two-generally consistent with other linkage and physical
maps of this region. In addition, our data, for the ﬁrst point linkage analyses of our large Nova Scotia NPD
kindred. The sizes of the intervals approximate thosetime, allow positioning of D18S478 and D18S66 rela-
tive to each other. Direct analysis of haplotypes reveals reported by Carstea et al. (1993, 1994) and others (Ge-
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Genome Data Base (1997)Website. http://gdbwww.gdb.orgH-nome Data Base [http://gdbwww.gdb.org]). The data
iggins JJ, Patterson MC, Dambrosia JM, Pikus AT, Pentchevpresented here have further characterized this region,
PG, Sato S, Brady RO, et al (1992) A clinical staging classi-ordering the previously inseparable loci D18S478 and
ﬁcation for type C Niemann-Pick disease. Neurology 42:D18S66, with the former on the distal side.
2286–2290We have mapped the NPD gene to proximal chromo-
Lathrop GM, Lalouel JM, Julier C, Ott J (1984) Strategies for
some 18q, to one or the other side of D18S1108. NPC multilocus linkage analysis in humans. Proc Natl Acad Sci
is located on the proximal side of these two segments. USA 81:3443–3446
Carstea et al. (1993) limited NPC to an Ç5-cM interval Liscum L, Faust JR (1987) Low density lipoprotein (LDL)–
between loci D18S44 and D18S66. We have recently mediated suppression of cholesterol synthesis and LDL up-
found in an NPC family evidence that greatly reduces take is defective in Niemann-Pick type C ﬁbroblasts. J Biol
the critical region, by establishing D18S1101 as the dis- Chem 262:17002–17008
Pentchev PG, Comly ME, Kruth HS, Vanier MT, Wenger DA,tal limit (T. L. Gillan, P. E. Neumann, D. M. Byers,
Patel S, Brady RO (1985) A defect in cholesterol esteriﬁca-D. C. Riddell, and W. L. Greer, unpublished results).
tion in Niemann-Pick disease (type C) patients. Proc NatlAdditional microsatellite markers in this region are
Acad Sci USA 82:8247–8251presently being generated from YACs, to further delin-
Pentchev PG, Kruth HS, Comly ME, Butler JD, Vanier MT,eate the NPC/NPD gene–containing region, with a view
Wenger DA, Patel S (1986) Type C Niemann-Pick disease:to positional cloning and characterization of the gene.
a parallel loss of regulatory responses in both the uptake
Despite the efforts of our group and others to under- and esteriﬁcation of low density lipoprotein-derived choles-
stand the basic biochemical defect responsible for NPD terol in cultured ﬁbroblasts. J Biol Chem 261:16775–16780
disease, the affected protein is still unidentiﬁed. Pentchev PG, Vanier MT, Suzuki K, Patterson MC (1995)
Niemann-Pick disease type C: a cellular cholesterol lipidosis.
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